Page last updated: 2024-08-18

framycetin and Liver Cirrhosis

framycetin has been researched along with Liver Cirrhosis in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	73 (81.11)	18.7374
1990's	6 (6.67)	18.2507
2000's	4 (4.44)	29.6817
2010's	6 (6.67)	24.3611
2020's	1 (1.11)	2.80

Authors

Authors	Studies
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Cross, TJ; Ellul, MA; Gholkar, SA	1
Bridgeman, MB; Dixit, D; Jawaro, T; Yang, A	1
Gluud, LL; Morgan, MY; Vilstrup, H	1
Shaikh, OS; Sundaram, V	1
Cao, GW; Dong, W; He, YQ; Lin, Y; Liu, Q; Tang, L; Wang, C; Wang, HY; Wu, HP; Wu, MC; Yan, HX; Yang, W; Yu, LX; Zhang, HL; Zou, SS	1
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B	1
Américo, MF; Caramori, CA; Corá, LA; da Silva Yamashiro, F; Miranda, JR; Romeiro, FG; Silva, GF	1
FALOON, WW; FISHER, CJ	1
GABUZDA, GJ; WEBSTER, LT	1
FENSTER, LF; KLATSKIN, G; TISDALE, WA	1
MOHNIKE, G	1
VOSMIK, J	1
DIGE-PETERSEN, H	1
CONN, HO	1
BROITMAN, SA; GOTTLIEB, LS; ZAMCHECK, N	1
DUGGAN, KC; FALOON, WW; FISHER, CJ; HAYMAN, H; RUBERT, MW	1
SHERLOCK, S	1
FRANKEN, FH	1
Johnston, AW; Smith, JF; Toghill, PJ	1
Asatoor, AM; Chamberlain, MJ; Emmerson, BT; Johnson, JR; Levi, AJ; Milne, MD	1
Angelico, R; Cerra, FB; Cline, B; Faulkenbach, L; Lyons, J; McMillen, M; Paysinger, J	1
Garcia Ramos, G; Márquez, MA; Ramos, C; Ramos-Uribe, MH; Uribe, M; Vargas, F; Villalobos, A	1
Escobedo, V; García-Ramos, G; Guevara, L; Lisker, R; Márquez, MA; Murillo, H; Uribe, M	1
Daschner, F; Kölle, EU; Lentzen, H	1
Epping, J; Fuchshofen, M; Richter, E	1
Bustamante Murga, V; Dugue de las Heras, C; Franco Vicario, R; Ibarmia Lahuerta, J; Miguel de la Villa, F; Sadaba Garay, F	1
Fukushima, K; Ito, A; Odagiri, S; Tarao, K; Yamazaki, R	1
Doffoël, M; Vetter, D	1
Allaz, JL; Blanc, P; Buttigieg, R; Daurès, JP; Desprez, D; Larrey, D; Liautard, J; Michel, H; Pageaux, G; Parelon, G	1
Antezana, C; Chesta, J	1
Chien, MC; Fagiuoli, S; Gavaler, JS; Van Thiel, DH; Wright, HI	1
Hall, PD; Ilsley, AH; Ossowicz, CJ; Plummer, JL; Whibley, C	1
Cumsille, F; Defilippi, C; Hurtado, C; Madrid, AM; Venegas, M	1
Bossone, CM	1
Schwager, A; Teichmann, W	1
Müting, D	3
Ritland, S	1
Caly, WR; de Sá, MF; Honain, NZ; Maffei, RA; Silva, EP; Strauss, E; Tramote, R	1
Calzetti, C; Fiaccadori, F; Missale, G; Pedretti, G	1
Dibildox, M; Garcia Ramos, G; Guillermo, E; Malpica, S; Nieto, L; Uribe, M; Vargas, F; Villallobos, A	1
Maddrey, WC	1
Haerting, J; Mantel, E; Nilius, R; Rink, C	1
Brunt, PW; Hawkes, CH; Horn, DB; Prescott, RJ	1
Attinà, D; Boccardi, V; Girelli, G	1
Fischer, JE	1
Bircher, J; Guggenheim, P; Haemmerli, UP; Müller, J	1
Staeffen, J	1
Devos, J; Guffens, JM; Pirotte, J	1
Abramsky, O; Goldschmidt, Z	1
Boyne, J; Mainous, EG	1
Bell, B; Jacobson, S	1
Goldstein, GB; Lam, KC; Mistilis, SP; Tall, AR	1
Gorbach, SL; Lai, D; Levitan, R	1
Kommerell, B	1
Juneja, I; Yovic, A	1
Czuba, M; Evans, WE; Greenberger, NJ; Kakos, GS; Spiegel, J	1
Koff, RS; Oliai, A; Sparks, RW	1
DiFulco, TJ; Galambos, JT; Rudman, D; Salam, AA; Smith, RB; Warren, WD	1
Galambos, JT; Rudman, D; Salam, AA; Smith, RB; Warren, WD	1
Conn, HO; Fessel, JM	1
Russell, RI	1
Brunt, PW; Hawkes, CH	1
Gniwotta, E; Neumann-Mangold, P; Schalm, J	1
Conn, HO; Elkington, SG; Floch, MH	1
Heaton, KW; Laidlaw, J; McCarthy, CF; Read, AE	1
Del Greco, F; Emmerman, J; Krumlovsky, FA; Parker, RH; Wisgerhof, M	1
Bircher, J; Haemmerli, UP; Hoffmann, K; Scollo-Lavizzari, G	2
Heinze, J; Momper, M; Müting, D; Schmidt, FH; Schwartz, M	1
Evans, GL; Faloon, WW	1
Phillips, SF; Summerskill, WH; Wolpert, E	1
Chalmers, TC; Chatterjee, GP; Madoff, MM; Resnick, RH	1
Harington, M; Keal, EE	1
Berk, DP; Chalmers, T	1
Boroń, P; Modzelewski, T	1
Hersh, T; McKechnie, JC	1
Aldrete, JS; Feinberg, JH; Summerskill, WH; Thorsell, F	1
Fung, WP; Khoo, OT	1
Müting, D; Reikowski, H; Reikowski, J	1
Blackburn, CR; Ma, MH; McLeod, JG	1
Clark, ML; Marin, GA; Senior, JR	1
Aggett, PW; Harrison, AW; Singer, H	1
Boutelier, D; Dupuy, R; Gourgon, R	1
Aoyagi, T; Evans, WB; Summerskill, WH	1
Artz, SA; Faloon, WW; Paes, IC	1

Reviews

10 review(s) available for framycetin and Liver Cirrhosis

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Hepatic encephalopathy due to liver cirrhosis. BMJ (Clinical research ed.), 2015, Aug-11, Volume: 351 Topics: Albumins; Amino Acids; Diagnosis, Differential; Diet; Disaccharides; Drug Resistance; Electroencephalography; Glycerol; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Neomycin; Neurologic Examination; Nucleic Acid Synthesis Inhibitors; Ornithine; Phenylbutyrates; Probiotics; Protein Synthesis Inhibitors; Rifamycins; Rifaximin; Terminal Care; Tomography, X-Ray Computed	2015
Management of Hepatic Encephalopathy: A Primer. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:7 Topics: Anti-Bacterial Agents; Disaccharides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Metronidazole; Neomycin; Practice Guidelines as Topic; Probiotics; Rifamycins; Rifaximin; Severity of Illness Index	2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane database of systematic reviews, 2016, May-06, Issue:5 Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols; Watchful Waiting	2016
Hepatic encephalopathy: pathophysiology and emerging therapies. The Medical clinics of North America, 2009, Volume: 93, Issue:4 Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc	2009
[Hepatic encephalopathy and liver transplantation]. Magyar sebeszet, 2012, Volume: 65, Issue:2 Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome	2012
[Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:12 Topics: Acute Disease; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Mannitol; Neomycin; Therapeutic Irrigation	1994
Branched chain amino acid therapy in liver disease. Journal of the American College of Nutrition, 1985, Volume: 4, Issue:6 Topics: Administration, Oral; Amino Acids; Amino Acids, Branched-Chain; Dietary Proteins; Glucose; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Neomycin; Nitrogen; Nutrition Disorders; Parenteral Nutrition	1985
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment. Archives of surgery (Chicago, Ill. : 1960), 1974, Volume: 108, Issue:3 Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease	1974
Recognition and management of acute and chronic hepatic encephalopathy. The Medical clinics of North America, 1973, Volume: 57, Issue:6 Topics: Acute Disease; Amines; Ammonia; Animals; Brain Edema; Central Nervous System; Chronic Disease; Diet Therapy; Dihydroxyphenylalanine; Exchange Transfusion, Whole Blood; Fatty Acids, Volatile; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Renal Dialysis	1973

Trials

13 trial(s) available for framycetin and Liver Cirrhosis

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study. BMC gastroenterology, 2013, Jan-16, Volume: 13 Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Anti-Bacterial Agents; C-Reactive Protein; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Hepatic Encephalopathy; Humans; Length of Stay; Liver Cirrhosis; Male; Middle Aged; Neomycin; Treatment Outcome	2013
Cirrhosis, encephalopathy, and improved results with metabolic support. Surgery, 1983, Volume: 94, Issue:4 Topics: Adolescent; Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Double-Blind Method; Electroencephalography; Female; Food, Formulated; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Prospective Studies; Random Allocation	1983
Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Digestive diseases and sciences, 1982, Volume: 27, Issue:12 Topics: Adult; Ammonia; Animals; Chronic Disease; Clinical Trials as Topic; Diabetes Complications; Dietary Proteins; Electrocardiography; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnesium Hydroxide; Male; Meat; Middle Aged; Neomycin; Plant Proteins, Dietary	1982
Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients. Digestive diseases and sciences, 1980, Volume: 25, Issue:12 Topics: Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Lactose; Lactose Intolerance; Liver Cirrhosis; Magnesium Hydroxide; Male; Neomycin	1980
[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:12 Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Placebos	1994
[Effects of neomycin on intestinal digestion, absorption and fermentation of carbohydrates in patients with liver cirrhosis: evidence for an alternative therapeutic mechanism in hepatic encephalopathy]. Revista medica de Chile, 1994, Volume: 122, Issue:4 Topics: Carbohydrate Metabolism; Digestion; Female; Fermentation; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactose; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Time Factors; Xylose	1994
Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. The American journal of gastroenterology, 2001, Volume: 96, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cisapride; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Norfloxacin; Severity of Illness Index; Time Factors	2001
Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepato-gastroenterology, 1992, Volume: 39, Issue:6 Topics: Adult; Aged; Brazil; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Placebos	1992
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial. The Italian journal of gastroenterology, 1991, Volume: 23, Issue:4 Topics: Aged; Ammonia; Chronic Disease; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Prospective Studies; Rifamycins; Rifaximin	1991
Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. Gastroenterology, 1985, Volume: 88, Issue:4 Topics: Adult; Amino Acids; Bilirubin; Diabetes Mellitus; Dietary Fiber; Dietary Proteins; Energy Intake; Female; Food, Fortified; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Neomycin; Plant Proteins; Psyllium; Tolbutamide	1985
EEG-provocative tests in the diagnosis of hepatic encephalopathy. Electroencephalography and clinical neurophysiology, 1973, Volume: 34, Issue:2 Topics: Brain Diseases; Dietary Proteins; Dose-Response Relationship, Drug; Electroencephalography; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Morphine; Neomycin; Quaternary Ammonium Compounds	1973
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. The New England journal of medicine, 1969, Aug-21, Volume: 281, Issue:8 Topics: Adult; Aged; Alcoholism; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestines; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Neomycin; Neurologic Manifestations; Sorbitol	1969

Other Studies

68 other study(ies) available for framycetin and Liver Cirrhosis

Article	Year
Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:4 Topics: Animals; Apoptosis; Carcinogens; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamine; Intestines; Lipopolysaccharides; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Neomycin; NF-kappa B; Polymyxin B; Rats; Reactive Oxygen Species; Toll-Like Receptor 4	2010
Blood ammonia levels in hepatic cirrhosis: their control by the oral administration of neomycin. The New England journal of medicine, 1957, May-30, Volume: 256, Issue:22 Topics: Administration, Oral; Ammonia; Humans; Liver Cirrhosis; Liver Function Tests; Neomycin	1957
Effect on portal blood ammonium concentration of administering methionine to patients with hepatic cirrhosis. The Journal of laboratory and clinical medicine, 1957, Volume: 50, Issue:3 Topics: Ammonia; Ammonium Compounds; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Methionine; Neomycin	1957
Acute staphylococcal enterocolitis complicating oral neomycin therapy in cirrhosis. The New England journal of medicine, 1960, Nov-17, Volume: 263 Topics: Colitis; Enterocolitis; Humans; Intestinal Diseases; Liver Cirrhosis; Neomycin; Staphylococcal Infections	1960
[HEPATIC COMA. DIAGNOSIS AND THERAPY]. Zeitschrift fur arztliche Fortbildung, 1963, May-15, Volume: 57 Topics: Chloramphenicol; Folic Acid; Fructose; Hepatic Encephalopathy; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Neomycin; Tetracycline; Vitamin B Complex	1963
[THE IMPORTANCE OF NEOMYCIN IN THE TREATMENT OF HEPATIC COMA IN SURGICAL DISEASES]. Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti, 1963, Volume: 42 Topics: Ammonia; Blood Chemical Analysis; Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Neomycin	1963
[TREATMENT OF LIVER CIRRHOSIS ACCOMPANIED BY ASCITES AND EDEMA]. Ugeskrift for laeger, 1963, Nov-22, Volume: 125 Topics: Anticoagulants; Ascites; Diet, Sodium-Restricted; Diuretics; Edema; Humans; Hydroflumethiazide; Liver Cirrhosis; Neomycin; Organomercury Compounds; Spironolactone; Vitamin K; Vitamins	1963
SPONTANEOUS PERITONITIS AND BACTEREMIA IN LAENNEC'S CIRRHOSIS CAUSED BY ENTERIC ORGANISMS. A RELATIVELY COMMON BUT RARELY RECOGNIZED SYNDROME. Annals of internal medicine, 1964, Volume: 60 Topics: Aeromonas; Alcoholism; Ascites; Bacteremia; Escherichia coli Infections; Geriatrics; Humans; Intestines; Liver Cirrhosis; Liver Function Tests; Neomycin; Novobiocin; Penicillins; Peritonitis; Sepsis; Streptococcal Infections; Streptomycin; Tetracycline	1964
INFLUENCE OF NEOMYCIN AND INGESTED ENDOTOXIN IN THE PATHOGENESIS OF CHOLINE DEFICIENCY CIRRHOSIS IN THE ADULT RAT. The Journal of experimental medicine, 1964, Apr-01, Volume: 119 Topics: Animals; Body Weight; Choline; Choline Deficiency; Endotoxins; Liver Cirrhosis; Liver Cirrhosis, Experimental; Neomycin; Pathology; Pharmacology; Rats; Research; Salmonella typhi	1964
EFFECT OF FAT-POOR DIET UPON NEOMYCIN INDUCED MALABSORPTION. Gastroenterology, 1964, Volume: 47 Topics: Ascites; Biomedical Research; Calcium; Calcium, Dietary; Carotenoids; Celiac Disease; Diet; Dietary Fats; Feces; Humans; Intestinal Absorption; Liver Cirrhosis; Neomycin; Nitrogen; Pharmacology; Potassium; Sodium; Toxicology	1964
HAEMATEMESIS IN PORTAL HYPERTENSION. The British journal of surgery, 1964, Volume: 51 Topics: Blood Transfusion; Cryosurgery; Esophageal and Gastric Varices; Gastric Hypothermia; Hematemesis; Hypertension; Hypertension, Portal; Hypothermia, Induced; Liver Cirrhosis; Liver Diseases; Neomycin; Prognosis; Surgical Procedures, Operative; Vasopressins	1964
[TREATMENT OF HEPATIC COMA]. Munchener medizinische Wochenschrift (1950), 1965, Jan-29, Volume: 107 Topics: Arginine Vasopressin; Drug Therapy; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Neomycin; Vasopressins	1965
Choreoathetosis in porto-systemic encephalopathy. Journal of neurology, neurosurgery, and psychiatry, 1967, Volume: 30, Issue:4 Topics: Athetosis; Basal Ganglia; Brain Diseases; Cerebellum; Cerebral Cortex; Chorea; Dietary Proteins; Female; Hematemesis; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Nerve Degeneration; Olivary Nucleus; Portacaval Shunt, Surgical	1967
Metabolic effects of oral neomycin. Clinical science, 1967, Volume: 33, Issue:1 Topics: Adult; Amino Acids; Celiac Disease; Chromatography; Diet; Fats; Feces; Glutens; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Neomycin; Nitrogen; Photometry; Potassium; Sodium; Urine	1967
[Comparative study of serum levels and urinary excretion following oral administration of paromomycin and neomycin (author's transl)]. Arzneimittel-Forschung, 1981, Volume: 31, Issue:11 Topics: Adult; Humans; Intestinal Absorption; Liver Cirrhosis; Male; Neomycin; Paromomycin; Portacaval Shunt, Surgical	1981
[Enterohepatic circulation in liver diseases]. Medizinische Klinik, 1980, Feb-01, Volume: 75, Issue:3 Topics: Animals; Barbiturates; Bile Acids and Salts; Biotransformation; Bisacodyl; Chloramphenicol; Cholestasis; Digitoxin; Enterohepatic Circulation; Humans; Liver Cirrhosis; Liver Diseases; Neomycin; Phenytoin; Rats; Spironolactone	1980
[Comparative study of changes in serum lipids in acutely decompensated cirrhotic patients: its evolution under treatment]. Revista espanola de las enfermedades del aparato digestivo, 1980, Volume: 57, Issue:4 Topics: Chromatography, Thin Layer; Humans; Lipids; Liver Cirrhosis; Male; Middle Aged; Neomycin; Tetracyclines	1980
[Faecal bacterial flora in cirrhotic patients and effects of administration of antibiotics or lactulose (author's transl)]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1980, Volume: 77, Issue:10 Topics: Anti-Bacterial Agents; Bacteria; Disaccharides; Feces; Humans; Lactulose; Liver Cirrhosis; Minocycline; Neomycin; Paromomycin	1980
Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:1 Topics: Adult; Ammonia; Chronic Disease; Dietary Proteins; Female; Gastric Emptying; Gastrointestinal Transit; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin	1994
[Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?]. MMW Fortschritte der Medizin, 2000, Jun-22, Volume: 142, Issue:25 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin	2000
Influence of intestinal flora on the development of fibrosis and cirrhosis in a rat model. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:11 Topics: Animals; Anti-Bacterial Agents; Carbon Tetrachloride; Ethanol; Intestines; Liver Cirrhosis; Male; Models, Animal; Neomycin; Polymyxin B; Rats	2000
The liver: a pharmacologic perspective. The Nursing clinics of North America, 1977, Volume: 12, Issue:2 Topics: Acetaldehyde; Alcoholism; Chemical and Drug Induced Liver Injury; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethanol; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Lactulose; Levodopa; Liver; Liver Cirrhosis; Liver Diseases; Microsomes, Liver; Neomycin; Oxidation-Reduction; Pharmaceutical Preparations; Spironolactone; Vasopressins	1977
[Conservative therapy of liver cirrhosis]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Jan-01, Volume: 32, Issue:1 Topics: Anabolic Agents; Diet, Sodium-Restricted; Humans; Lactulose; Liver Cirrhosis; Neomycin; Prednisolone	1977
[Clinical picture and therapy of portal-systemic encephalopathy (author's transl)]. Leber, Magen, Darm, 1977, Volume: 7, Issue:4 Topics: Acetates; Acidosis; Alcoholism; Amino Acids; Ammonia; Astrocytes; Dietary Proteins; Diuretics; Hemorrhage; Hepatic Encephalopathy; Humans; Hypokalemia; Lactulose; Liver; Liver Cirrhosis; Neomycin; Potassium; Skin Manifestations; Water-Electrolyte Balance	1977
[Therapy of hepatic insufficiency]. Fortschritte der Medizin, 1977, Aug-25, Volume: 95, Issue:32 Topics: Alcoholism; Ammonia; Dietary Proteins; Exchange Transfusion, Whole Blood; Hepatic Encephalopathy; Humans; Hypertension, Portal; Intensive Care Units; Liver Cirrhosis; Liver Diseases; Neomycin; Renal Dialysis; Urea; Water-Electrolyte Balance	1977
[Medical treatment of liver cirrhosis]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1976, Mar-20, Volume: 96, Issue:8 Topics: Adrenal Cortex Hormones; Ascites; Diuretics; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Neomycin; Prednisone	1976
[Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis]. Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1985, Volume: 45, Issue:6 Topics: Aged; Ammonia; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Tremor	1985
Influence of orally administered antibiotics on anti-T agglutinin of normal subjects and of cirrhotic patients. Vox sanguinis, 1974, Volume: 27, Issue:3 Topics: Agglutinins; Antibodies, Bacterial; Antibody Formation; Antigens, Bacterial; Bacitracin; Blood Proteins; Enterobacteriaceae; Epitopes; Erythrocytes; gamma-Globulins; Hemagglutination Tests; Humans; Isoantibodies; Lectins; Liver Cirrhosis; Neomycin; Neuraminidase	1974
Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet (London, England), 1966, Apr-23, Volume: 1, Issue:7443 Topics: Brain Diseases; Diet Therapy; Dietary Proteins; Disaccharides; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Sorbitol	1966
Treatment of chronic hepatic encephalopathy. Lancet (London, England), 1970, Aug-29, Volume: 2, Issue:7670 Topics: Colostomy; Diet Therapy; Disaccharides; Humans; Ileostomy; Lactose; Liver Cirrhosis; Liver Diseases; Mental Disorders; Middle Aged; Neomycin; Nervous System Diseases	1970
[Hepatic coma in cirrhosis]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1969, Apr-08, Volume: 45, Issue:17 Topics: Ammonia; Blood Transfusion; Chemical and Drug Induced Liver Injury; Chlorine; Diagnosis, Differential; Electroencephalography; Gastrointestinal Hemorrhage; Glucose; Hepatic Encephalopathy; Hepatitis; Humans; Hydrocortisone; Hydrotherapy; Hyponatremia; Liver Cirrhosis; Neomycin; Neurologic Manifestations; Nitrogen; Perfusion	1969
Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose. Digestion, 1974, Volume: 10, Issue:6 Topics: Ammonia; Blood Urea Nitrogen; Brain Diseases; Chlorides; Chronic Disease; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Liver Cirrhosis; Liver Function Tests; Neomycin; Potassium; Sodium	1974
Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa. Surgery, 1974, Volume: 75, Issue:2 Topics: Adult; Aged; Blood Transfusion; Brain; Budd-Chiari Syndrome; Dihydroxyphenylalanine; Drug Therapy, Combination; Electroencephalography; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Neomycin; Vena Cava, Inferior	1974
Hepatic coma after multiple dental extractions: report of case. Journal of oral surgery (American Dental Association : 1965), 1974, Volume: 32, Issue:9 Topics: Anesthesia, Local; Anti-Bacterial Agents; Epinephrine; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Lidocaine; Liver Cirrhosis; Male; Middle Aged; Neomycin; Oral Hemorrhage; Penicillins; Periodontal Diseases; Postoperative Complications; Procaine; Tooth Extraction	1974
Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy. Scandinavian journal of gastroenterology, 1973, Volume: 8, Issue:6 Topics: Blood Urea Nitrogen; Coma; Glomerular Filtration Rate; Hepatic Encephalopathy; Humans; Kidney Diseases; Liver Cirrhosis; Neomycin; Octopamine; Uremia	1973
Intestinal microflora in patients with alcoholic cirrhosis: urea-splitting bacteria and neomycin resistance. Gastroenterology, 1972, Volume: 62, Issue:2 Topics: Alcoholism; Bacteria; Candida; Drug Resistance, Microbial; Duodenum; Feces; Humans; Ileum; Intestines; Jejunum; Klebsiella; Liver Cirrhosis; Male; Neomycin; Proteus; Staphylococcus; Stomach; Streptococcus; Urea	1972
[Therapy of liver cirrhosis]. Minerva medica, 1972, Dec-26, Volume: 63, Issue:93 Topics: Alanine Transaminase; Aspartate Aminotransferases; Diet, Sodium-Restricted; Esophageal and Gastric Varices; Furosemide; Glucocorticoids; Hepatic Encephalopathy; Humans; Immunosuppressive Agents; Liver Cirrhosis; Neomycin; Spironolactone; Water-Electrolyte Balance	1972
Hepatic decerebration. Neurology, 1972, Volume: 22, Issue:5 Topics: Alcoholism; Blood Transfusion; Cephalothin; Decerebrate State; Diet Therapy; Glucose; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Mannitol; Middle Aged; Movement Disorders; Neomycin	1972
Subtotal portacaval shunt obliteration for chronic hepatic encephalopathy. Annals of surgery, 1973, Volume: 177, Issue:3 Topics: Adult; Brain Diseases; Catheterization; Chronic Disease; Diet Therapy; Diet, Sodium-Restricted; Dietary Proteins; Female; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Neomycin; Portacaval Shunt, Surgical; Portal Vein; Radiography; Tetracycline	1973
Sensori-neural hearing loss in alcoholic cirrhosis. Digestion, 1973, Volume: 8, Issue:3 Topics: Alcoholism; Audiometry; Auditory Pathways; Deafness; Hearing Disorders; Hearing Tests; Humans; Liver Cirrhosis; Male; Neomycin; Portacaval Shunt, Surgical	1973
Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. The Journal of clinical investigation, 1973, Volume: 52, Issue:9 Topics: Administration, Oral; Amino Acids; Ammonia; Ammonium Chloride; Bilirubin; Body Surface Area; Body Water; Body Weight; Carbon Isotopes; Caseins; Creatinine; Electroencephalography; Hemoglobins; Humans; Injections, Intravenous; Lactalbumin; Liver Cirrhosis; Neomycin; Ovalbumin; Portacaval Shunt, Surgical; Tritium; Urea	1973
Comparison of the effect of various amino acids upon the blood ammonia concentration of patients with liver disease. The American journal of clinical nutrition, 1973, Volume: 26, Issue:9 Topics: Administration, Oral; Adult; Alcoholism; Amino Acids; Ammonia; Aspartate Aminotransferases; Bilirubin; Dose-Response Relationship, Drug; Drug Synergism; Fatty Liver; Female; Hematocrit; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Neomycin; Nitrogen; Prothrombin Time; Serum Albumin; Structure-Activity Relationship; Urea	1973
Lactulose in the treatment of acute hepatic encephalopathy. The American journal of the medical sciences, 1973, Volume: 266, Issue:2 Topics: Acute Disease; Ammonia; Connecticut; Dietary Proteins; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Nitrogen	1973
Clinical aspects of alterations in bile acid metabolism--the wrong bile acids in the wrong place. Scottish medical journal, 1973, Volume: 18, Issue:5 Topics: Bile Acids and Salts; Biliary Tract Diseases; Celiac Disease; Chenodeoxycholic Acid; Cholestasis; Colonic Diseases; Diarrhea; Hepatitis A; Ileum; Intestinal Mucosa; Intestine, Small; Lithocholic Acid; Liver Cirrhosis; Malabsorption Syndromes; Neomycin; Pancreatitis; Pruritus; Zollinger-Ellison Syndrome	1973
The current status of the EEG in liver disease. The American journal of digestive diseases, 1974, Volume: 19, Issue:1 Topics: Alpha Rhythm; Cerebral Cortex; Consciousness; Dietary Proteins; Electroencephalography; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Morphine; Neomycin; Portacaval Shunt, Surgical; Quaternary Ammonium Compounds	1974
[Therapy of hyperammonemia in liver diseases with special reference to neomycin]. Zeitschrift fur Allgemeinmedizin, 1974, Feb-10, Volume: 50, Issue:4 Topics: Adult; Ammonia; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Neomycin	1974
Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy. British medical journal, 1966, May-21, Volume: 1, Issue:5498 Topics: Adult; Aged; Ammonia; Blood; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Lactobacillus acidophilus; Liver Cirrhosis; Male; Middle Aged; Neomycin	1966
Dialysis in treatment of neomycin overdosage. Annals of internal medicine, 1972, Volume: 76, Issue:3 Topics: Acute Kidney Injury; Adult; Alcoholism; Biological Assay; Female; Hepatic Encephalopathy; Humans; Kidney Function Tests; Liver Cirrhosis; Neomycin; Renal Dialysis; Time Factors	1972
Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature. The American journal of medicine, 1971, Volume: 51, Issue:2 Topics: Aged; Ammonia; Brain Diseases; Cathartics; Chronic Disease; Colon; Diarrhea; Dietary Proteins; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Lactobacillus; Liver Cirrhosis; Male; Middle Aged; Neomycin; Portal System; Urease	1971
[Methods and clinical significance of femin ammonia determination]. Deutsche medizinische Wochenschrift (1946), 1970, Jun-26, Volume: 95, Issue:26 Topics: Ammonia; Clinical Enzyme Tests; Digestive System; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glutamate Dehydrogenase; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Indican; Indicators and Reagents; Liver Cirrhosis; Liver Diseases; Methods; Neomycin; Phenols	1970
Precipitating factors in genesis of hepatic coma. New York state journal of medicine, 1970, Dec-01, Volume: 70, Issue:23 Topics: Acute Kidney Injury; Ammonia; Diuretics; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypokalemia; Liver Cirrhosis; Male; Neomycin; Portacaval Shunt, Surgical; Potassium; Sulfates	1970
Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid. The New England journal of medicine, 1970, Jul-23, Volume: 283, Issue:4 Topics: Adult; Ammonia; Colon; Feces; Female; Hepatic Encephalopathy; Humans; Hydroxamic Acids; Intestinal Absorption; Intubation, Gastrointestinal; Liver Cirrhosis; Male; Middle Aged; Neomycin; Perfusion; Therapeutic Irrigation; Urease	1970
Renal function and fecal flora after colon bypass. Archives of surgery (Chicago, Ill. : 1960), 1970, Volume: 101, Issue:3 Topics: Colon; Diet Therapy; Dietary Proteins; Feces; Glomerular Filtration Rate; Hepatic Encephalopathy; Humans; Intestine, Small; Kidney; Kidney Concentrating Ability; Kidney Diseases; Kidney Function Tests; Liver Cirrhosis; Neomycin	1970
Cirrhosis and hypoxia. Proceedings of the Royal Society of Medicine, 1970, Volume: 63, Issue:6 Topics: Alcoholism; Diet Therapy; Dietary Proteins; Humans; Hypoxia; Liver Cirrhosis; Lung; Male; Middle Aged; Neomycin; Oxygen; Pulmonary Circulation; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Respiratory Tract Infections	1970
Deafness complicating antibiotic therapy of hepatic encephalopathy. Annals of internal medicine, 1970, Volume: 73, Issue:3 Topics: Adult; Aged; Alcoholism; Ascites; Audiometry; Creatinine; Deafness; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Paromomycin; Time Factors	1970
[Exchange transfusion as a method of treatment of hepatic coma]. Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1970, Volume: 30, Issue:1 Topics: Acid-Base Equilibrium; Adolescent; Adult; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Bilirubin; Exchange Transfusion, Whole Blood; Female; Glucocorticoids; Glucose; Hepatic Encephalopathy; Hepatitis A; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Neomycin; Potassium; Sodium; Time Factors	1970
Exchange transfusion in hepatic coma. A review of 19 cases. The American journal of gastroenterology, 1971, Volume: 56, Issue:1 Topics: Adolescent; Adult; Alanine Transaminase; Ammonia; Anesthesia, Inhalation; Autopsy; Bilirubin; Blood Preservation; Citrates; Dietary Proteins; Enema; Exchange Transfusion, Whole Blood; Female; Glucose; Glucosephosphate Dehydrogenase Deficiency; Halothane; Hemolysis; Hepatic Encephalopathy; Hepatitis; Hepatitis A; Humans; Infusions, Parenteral; Liver; Liver Cirrhosis; Male; Middle Aged; Neomycin; Pancreatitis; Prednisone; Renal Dialysis	1971
[Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels]. La Clinica terapeutica, 1967, Aug-31, Volume: 42, Issue:4 Topics: Ammonia; Arginine; Aspartic Acid; Bacteria; Female; Glutamates; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Malates; Male; Neomycin	1967
Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid. Gastroenterology, 1968, Volume: 54, Issue:1 Topics: Aged; Ammonia; Animals; Bilirubin; Budd-Chiari Syndrome; Dogs; Fasting; Female; Hepatic Encephalopathy; Hepatitis; Humans; Hydroxamic Acids; Liver Cirrhosis; Liver Diseases; Male; Metabolic Diseases; Middle Aged; Necrosis; Neomycin; Portacaval Shunt, Surgical; Serum Albumin; Urea; Urease	1968
Treatment of chronic hepatic encephalopathy with lactulose. The Medical journal of Australia, 1968, Jul-27, Volume: 2, Issue:4 Topics: Alcoholism; Apraxias; Brain Diseases; Diet Therapy; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Proteins	1968
[On the effect of neomycin on blood ammonia, free amino acids and free phenols in serum and urine in liver cirrhosis]. Die Medizinische Welt, 1968, May-11, Volume: 19 Topics: Adult; Aged; Amino Acids; Ammonia; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Neomycin; Phenols	1968
[Treatment of chronic porto-systemic encephalopathy with lactulose]. Schweizerische medizinische Wochenschrift, 1969, Apr-19, Volume: 99, Issue:16 Topics: Brain Diseases; Chronic Disease; Disaccharides; Humans; Liver Cirrhosis; Neomycin; Portal System; Vascular Diseases	1969
Long-term treatment of portal-systemic encephalopathy with lactulose. Australasian annals of medicine, 1969, Volume: 18, Issue:2 Topics: Adult; Brain Diseases; Carbohydrates; Chronic Disease; Diet Therapy; Dietary Proteins; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Methods; Middle Aged; Neomycin; Portal System	1969
Studies of malabsorption occurring in patients with Laennec's cirrhosis. Gastroenterology, 1969, Volume: 56, Issue:4 Topics: Adult; Aged; Biopsy; Celiac Disease; Duodenum; Feces; Female; Humans; Insulin; Intestinal Absorption; Intestine, Small; Kidney Function Tests; Lipid Metabolism; Liver Cirrhosis; Male; Middle Aged; Neomycin; Pancreatic Diseases; Pancreatitis; Prospective Studies; Retrospective Studies; Schilling Test; Xylose	1969
The treatment of hepatic encephalopathy by colectomy: case report and review of the literature. Canadian Medical Association journal, 1965, Oct-30, Volume: 93, Issue:18 Topics: Alcoholism; Colectomy; Diet Therapy; Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Portacaval Shunt, Surgical	1965
[Meningeal listeriosis in a cirrhotic cured by early antibiotic therapy]. Revue internationale d'hepatologie, 1965, Volume: 15, Issue:6 Topics: Colistin; Humans; Hydrocortisone; Liver Cirrhosis; Male; Meningitis, Listeria; Middle Aged; Neomycin; Penicillins	1965
Gastrointestinal urease in man. II. Urea hydrolysis and ammonia absorption in upper and lower gut lumen and the effect of neomycin. Gut, 1966, Volume: 7, Issue:6 Topics: Adult; Ammonia; Female; Humans; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Neomycin; Urea; Urease	1966
Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy. Gastroenterology, 1966, Volume: 51, Issue:6 Topics: Ammonia; Blood Chemical Analysis; Feces; Hepatic Encephalopathy; Humans; Hypokalemia; In Vitro Techniques; Liver Cirrhosis; Male; Middle Aged; Neomycin; Urine	1966